How the LDT Final Rule’s Exemptions Apply to Oncology Labs
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
A laboratory safety expert shares the most common CLIA citations from recent lab inspections, and how your lab can avoid similar problems.
Areas to address when preparing for your next CLIA inspection, based on recent data on top CLIA deficiencies
How the Eliminating Kickbacks in Recovery Act of 2018 (EKRA) came to be, what laboratory leaders should know about it, and how to comply
When selling your laboratory, in order to remain compliant with federal code, EKRA is something you will want to consider
How widespread is corruption in the lab—and what can be done to combat it?
Recent enforcement actions show that clinical laboratories must remain vigilant about compliance relating to these areas
Healthcare attorneys explain three digital pathology models for laboratories to be aware of.
Which staff members lab professionals should consider when developing their exposure control plans to ensure OSHA compliance.
How lab leaders can manage the data security risks of staff using personal devices for work-related purposes.
The compliance risks of giving referral sources software or equipment to ensure the security of protected health information.